Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Versus Graft Host Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT02881047
What this trial is testing

Ablative Fractional Laser for Sclerotic GVHD-Associated Joint Contractures

Who this might be right for
Subjects With Severe, Refractory Sclerotic Skin Changes
Abramson Cancer Center at Penn Medicine 8
Testing effectiveness (Phase 2)Study completedNCT04540133
What this trial is testing

Dexamethasone Solution and Dexamethasone in Mucolox™

Who this might be right for
Oral Lichen PlanusMucous Membrane PemphigoidPemphigus Vulgaris+1 more
University of California, San Francisco 29
Testing effectiveness (Phase 2)Study completedNCT00589563
What this trial is testing

Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseInfection+8 more
City of Hope Medical Center 32
Testing effectiveness (Phase 2)Study completedNCT00248365
What this trial is testing

Theralux Extracorporeal Photochemotherapy (ECP) in Patients With Extensive Chronic Graft Versus Host Disease (GvHD)

Who this might be right for
Graft vs Host Disease
Kiadis Pharma 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07808112
What this trial is testing

CSF-1R Inhibitor, Axatilimab, for Prevention of Acute and Chronic GVHD After HLA-Matched Related and Unrelated Donor Allogeneic Stem Cell Transplantation

Who this might be right for
Graft -Versus-host-disease
Medical College of Wisconsin 72
Early research (Phase 1)Study completedNCT01155817
What this trial is testing

Phase 1 Nilotinib in Steroid Dependent/Refractory Chronic Graft Versus Host Disease

Who this might be right for
Bone Marrow Transplant FailureLymphoma, Non-HodgkinLymphoma, T-Cell, Peripheral
Stanford University 33
Testing effectiveness (Phase 2)Active Not RecruitingNCT06852768
What this trial is testing

Study of d-MAPPS™ Ophthalmic Solution, Safety, Tolerability, and Efficacy in the Treatment of Chronic Ocular Graft-Versus-Host Disease (oGVHD)

Who this might be right for
oGHVD
Regenerative Ocular Immunobiologics LLC 15
Testing effectiveness (Phase 2)Looking for participantsNCT04710576
What this trial is testing

Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)

Who this might be right for
Chronic Graft-versus-host-disease
Syndax Pharmaceuticals 296
Not applicableActive Not RecruitingNCT06160986
What this trial is testing

Horizons Chronic Graft-Versus-Host-Disease Study

Who this might be right for
Graft Vs Host DiseaseCoping SkillsQuality of Life+1 more
University of Miami 20
Testing effectiveness (Phase 2)Study completedNCT01956903
What this trial is testing

Treatment of Refractory Acute Graft-Versus-Host Disease by Sequential Infusion of Allogenic Mesenchymal Stem Cell.

Who this might be right for
Chronic Graft-Versus-Host Disease
Grupo Espanol de trasplantes hematopoyeticos y terapia celular 15
Testing effectiveness (Phase 2)Study completedNCT00136396
What this trial is testing

Rituximab Therapy for Steroid-Refractory Chronic Graft Versus Host Disease

Who this might be right for
Graft vs Host Disease
Dana-Farber Cancer Institute 30
Large-scale testing (Phase 3)Looking for participantsNCT06682169
What this trial is testing

Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Moderate to Severe Chronic Graft-versus-host Disease

Who this might be right for
Graft-versus-host Disease
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 182
Not applicableWithdrawnNCT04015947
What this trial is testing

Allogeneic Skin Grafting

Who this might be right for
GVHD
University of Minnesota
Not applicableStudy completedNCT01042509
What this trial is testing

Combination of Alemtuzumab and Rituximab at Low-doses in Refractory Chronic Graft-Versus-Host Disease

Who this might be right for
Graft vs Host Disease
Hospital Universitario Dr. Jose E. Gonzalez 15
Testing effectiveness (Phase 2)Study completedNCT01680965
What this trial is testing

Ofatumumab as Primary Therapy of Chronic Graft Versus Host Disease

Who this might be right for
Chronic Graft Versus Host Disease
H. Lee Moffitt Cancer Center and Research Institute 44
Very early researchStudy completedNCT04146207
What this trial is testing

SHR0302 and Steroid As First Line Therapy for Chronic GVHD

Who this might be right for
Chronic GVHD
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 28
Early research (Phase 1)Study completedNCT00004232
What this trial is testing

Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Northwestern University
Testing effectiveness (Phase 2)Looking for participantsNCT03805477
What this trial is testing

Nintedanib in Patients With Bronchiolitis Obliterans Syndrome Following Hematopoietic Stem Cell Transplantation

Who this might be right for
Bronchiolitis Obliterans Syndrome (BOS)Bronchiolitis Obliterans (BO)
University Hospital, Basel, Switzerland 20
Testing effectiveness (Phase 2)Study completedNCT00144677
What this trial is testing

Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation

Who this might be right for
Acute Myelogenous LeukemiaGraft Versus Host DiseaseAcute Lymphoblastic Leukemia+4 more
Dana-Farber Cancer Institute 30
Not applicableEnded earlyNCT02458859
What this trial is testing

Trial of PICO Versus Standard Care in Chronic and Sub-acute Wounds

Who this might be right for
Wounds
Smith & Nephew, Inc. 62
Next Page